Celestica (NYSE:CLS) Stock Price Up 2.5% - What's Next?

Key Points

• Celestica shares rose 2.5% to about $347.88, with trading volume 29% above the average. The company has a $40 billion market capitalization and a beta of 2.06.
• Analysts remain broadly bullish, with a consensus “Moderate Buy” rating and an average price target of $438.86; recent targets range from $406 to $485.
• Celestica exceeded quarterly expectations, reporting $2.54 in earnings per share versus $2.29 expected and $4.68 billion in revenue, up 62.4% year over year. However, insiders sold $128.1 million of stock over the past three months.

Shares of Celestica, Inc. (NYSE:CLS - Get Free Report) TSE: CLS shot up 2.5% on Thursday . The stock traded as high as $365.52 and last traded at $347.8840. Approximately 3,180,398 shares traded hands during mid-day trading, an increase of 29% from the average session volume of 2,469,993 shares. The stock had previously closed at $339.46.

Analysts Set New Price Targets

CLS has been the subject of a number of analyst reports. Barclays lowered their price objective on Celestica from $430.00 to $406.00 and set an "overweight" rating for the company in a research report on Friday, August 7th. Citigroup boosted their price target on shares of Celestica from $338.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, April 29th. Wolfe Research lifted their target price on shares of Celestica from $425.00 to $475.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 29th. JPMorgan Chase & Co. boosted their target price on shares of Celestica from $445.00 to $485.00 and gave the company an "overweight" rating in a report on Wednesday, July 29th. Finally, TD Securities raised shares of Celestica from a "hold" rating to a "buy" rating and set a $430.00 price target on the stock in a research report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, Celestica presently has a consensus rating of "Moderate Buy" and a consensus price target of $438.86.

Celestica Stock Up 2.5%

The company has a quick ratio of 0.68, a current ratio of 1.23 and a debt-to-equity ratio of 0.32. The stock has a 50 day simple moving average of $350.42 and a 200 day simple moving average of $334.97. The stock has a market cap of $40.00 billion, a price-to-earnings ratio of 36.16 and a beta of 2.06.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last issued its earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, topping analysts' consensus estimates of $2.29 by $0.25. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The company had revenue of $4.68 billion for the quarter, compared to analyst estimates of $4.30 billion. During the same period in the prior year, the firm earned $1.39 earnings per share. Celestica's revenue for the quarter was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. As a group, analysts expect that Celestica, Inc. will post 9.97 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Robert Mionis sold 98,453 shares of the firm's stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $368.99, for a total value of $36,328,172.47. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Michael Max Wilson sold 4,168 shares of Celestica stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $333.31, for a total value of $1,389,236.08. Following the transaction, the director owned 24,718 shares of the company's stock, valued at $8,238,756.58. This trade represents a 14.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 337,225 shares of company stock worth $128,112,965 over the last three months. 1.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Celestica

Several large investors have recently bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Celestica during the fourth quarter valued at about $28,000. Ascentis Independent Advisors purchased a new stake in Celestica in the 1st quarter valued at about $29,000. Swiss RE Ltd. bought a new position in shares of Celestica during the 4th quarter worth approximately $29,000. Cullen Frost Bankers Inc. purchased a new position in shares of Celestica in the 4th quarter worth approximately $30,000. Finally, Sittner & Nelson LLC bought a new position in shares of Celestica in the fourth quarter valued at approximately $31,000. 67.38% of the stock is currently owned by institutional investors.

About Celestica

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source